Appointment allows Professor Taskén to retain an affiliation with NCMM after his departure from the Centre
NCMM is delighted to announce that Dr. Emma Haapaniemi has been recruited as Group Leader for Precision Medicine
You can now sign up for the 9th annual Nordic EMBL Partnership Meeting
Lynn Butler appointed as Young Associate Investigator on recruitment to the Arctic University of Norway (UiT)
Congratulations to Kinga Aurelia Gawel and Eva Cunha who have both been awarded Marie Skłodowska-Curie (MSCA) Individual Fellowships
Congratulations to the Mathelier Group on the publication of their article, ‘Put Science First and Formatting Later’ in EMBO Reports’ Opinion series
The four Nordic EMBL Partnership Directors were interviewed alongside Silke Schumacher, Director of International Relations at EMBL (European Molecular Biology Laboratory)
The NCMM Annual Report for 2017 is now available to view online
Nordic EMBL Partner centre, MIMS (Molecular Infection Medicine Sweden) has announced that that Dr. Oliver Billker from the Wellcome Sanger Institute, Cambridge, UK, has been recruited as the centre's future director
Multi-drug resistant tuberculosis is increasing, with people dying due to a lack of effective antibiotic treatment. Researchers from all over the world have joined together to form the EU-funded anTBiotic consortium to discover new drugs and better treatment regimens
NCMM’s Associate and Young Associate Investigators, Group Leaders and stakeholders gathered at Oslo’s Grand Hotel for the third annual NCMM Network Meeting on the 26 and 27 February.
The University of Helsinki has recruited Professor Mark Daly, of the Broad Institute of MIT and Harvard and Massachusetts General Hospital, to lead Nordic EMBL Partner the Institute for Molecular Medicine Finland (FIMM).
The University of Oslo is now seeking outstanding candidates for the position of Centre Director of NCMM.
Grant awarded to Irep Gözen for her project: Nano- and Micro-Materials Interfaces for Migratory Artificial Cells.
Ragnhild Lothe has stepped down as Chair, and will be replaced by Jens Petter Berg
Trial to determine how aspirin can improve disease free survival in patients treated with resection for colorectal cancer liver metastases (CRCLM) is now underway.
Researchers from Norway have participated in a study that explores Short QT Syndrome, a genetic disease of the heart’s electrical system
Science communication took on a whole new meaning when NCMM Group Leader, Irep Gözen, head of the Bionanotechnology and Membrane Systems Group, addressed thousands of students on Wednesday 6 December.
The Mathelier Group at NCMM has recently been involved in the update of the JASPAR and ReMap databases, two key resources for the scientific community
Findings of study from NCMM Group Leaders, together with collaborators at Institute for Cancer Research at Oslo University Hospital, published in Nature Communications
Director of NCMM, Professor Kjetil Taskén, has been appointed as the Head and Director of Institute for Cancer Research Oslo University Hospital (OUH)
NCMM is delighted to announce the official appointment of six new Associate Investigators and five new Young Associate Investigators
October edition of the newsletter now available
NCMM is pleased to announce that its Director, Professor Kjetil Taskén, has been formally appointed to the IMI Scientific Committee.
Research from the Morth Group shows that Zinc-binding plays an important role in the sensing and regulation of cellular pH in the human brain. Findings published in Nature Group's Scientific Reports